In pancreatic ductal adenocarcinoma, IL-17 not only recruited neutrophils and activated neutrophil extracellular traps but also mediated the exclusion of cytotoxic CD8 T cells from tumors, with a higher expression of IL17 representing poorer clinical outcomes (Zhang et al., 2020). The gene discussed is IL17A; the disease is pancreatic ductal adenocarcinoma.